Cellectar Biosciences, Inc. (CLRB)
NASDAQ·Healthcare·Biotechnology
$2.62
-1.50%
Mkt Cap $8.78M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (2 analysts)
$11.00
Range $11.00 – $11.00
Implied Upside
+319.8%
Consensus $11.00 vs current $2.62
NASDAQ·Healthcare·Biotechnology
$2.62
-1.50%
Mkt Cap $8.78M
Buy
1
Hold
0
Sell
0
Price Target (2 analysts)
$11.00
Range $11.00 – $11.00
+319.8%
Consensus $11.00 vs current $2.62